Atlas Trials

Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus

Clinical trial NCT01603121 · TERMINATED

Trial details

NCT number
NCT01603121
Sponsor
Eastern Virginia Medical School
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2012-02-01
Primary completion
2013-05-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.